2018
- Submission to the Select Committee on Red Tape Inquiry into the effect of red tape on health services (January) Friday, 29 January 2021
- Medicines Australia’s response to TGA’s Consultation paper on Prescription strong (Schedule 8) opioid use and misuse in Australia (March) Friday, 29 January 2021
- Medicine’s Australia’s response to the TGA public consultation on the management and communication of medicines shortages (March) Friday, 29 January 2021
- Medicines Australia Consultation: Proposal to change the current good manufacturing practice (GMP) fees and charges (March) Friday, 29 January 2021
- Joint Standing Committee on Treaties Inquiry into the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (TPP-11) (April) Friday, 29 January 2021
- TGA Consultation: Options for the implementation of a claimer for efficacy assessed non-prescription medicines (June) Friday, 29 January 2021
- Medicines Australia’s Response to the Consultation on the draft Treasury Laws Amendment (R&D) Bill 2018 (July) Friday, 29 January 2021
- Medicines Australia submission – PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types (August) Friday, 29 January 2021
- Medicines Australia submission – Senate Community Affairs References Committee – Inquiry into the My Health Record system Friday, 29 January 2021
- Medicines Australia response on the Therapeutic Goods Administration (TGA) consultation paper ‘Proposal for the regulation of IVD companion diagnostics’ Friday, 29 January 2021
- Medicines Australia – Consideration of proposed listing changes to antibiotic repeats on the Pharmaceutical Benefits Scheme (December) Friday, 29 January 2021
- Consultation on adoption of European Union guidelines in Australia Friday, 25 September 2020
- Medicines Australia submission to provide input on the public consultation on the draft Intellectual Property (IP) regulations (December) Tuesday, 25 December 2018
- Medicines Australia submission to the consultation on the Intellectual Property Laws Amendment Bill 2018 (September) Tuesday, 25 September 2018
- Medicines Australia submission Pharmaceutical Society of Australia (PSA) 2023 Discussion Paper (September) Tuesday, 25 September 2018
- Medicines Australia response to Science and Technology Australia – Medical Research Future Fund 2018-2020 Priorities Consultation (September) Tuesday, 25 September 2018
- Medicines Australia response – World Health Organisation Global Patient Safety Challenge – Medication without harm (September) Tuesday, 25 September 2018
- Medicines Australia Federal Budget Submission 2018-2019 Sunday, 29 July 2018
- Medicines Australia submission – Department of Foreign Affairs and Trade (DFAT) – Australia-European Union Free Trade Agreement (AEUFTA) Wednesday, 25 July 2018
- Medicines Australia submission on the Therapeutic Goods Administration (TGA) consultation paper ‘Boxed Warning Guidance’ Monday, 25 June 2018
- Medicines Australia submission to the Joint Standing Committee on Trade and Investment Growth; Inquiry into Austrade’s role in attracting investment in Australia Monday, 25 June 2018
- Medicines Australia response to the Therapeutic Goods Administration (TGA) consultation paper ‘Transition to eCTD only for prescription medicines Friday, 25 May 2018